Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...
Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback